112 related articles for article (PubMed ID: 20513351)
21. RS4-type resistant starch prevents high-fat diet-induced obesity via increased hepatic fatty acid oxidation and decreased postprandial GIP in C57BL/6J mice.
Shimotoyodome A; Suzuki J; Fukuoka D; Tokimitsu I; Hase T
Am J Physiol Endocrinol Metab; 2010 Mar; 298(3):E652-62. PubMed ID: 20009028
[TBL] [Abstract][Full Text] [Related]
22. The expression of SIRT1 in nonalcoholic fatty liver disease induced by high-fat diet in rats.
Deng XQ; Chen LL; Li NX
Liver Int; 2007 Jun; 27(5):708-15. PubMed ID: 17498258
[TBL] [Abstract][Full Text] [Related]
23. Coenzyme Q10 supplementation lowers hepatic oxidative stress and inflammation associated with diet-induced obesity in mice.
Sohet FM; Neyrinck AM; Pachikian BD; de Backer FC; Bindels LB; Niklowitz P; Menke T; Cani PD; Delzenne NM
Biochem Pharmacol; 2009 Dec; 78(11):1391-400. PubMed ID: 19632207
[TBL] [Abstract][Full Text] [Related]
24. Improvement for high fat diet-induced hepatic injuries and oxidative stress by flavonoid-enriched extract from Nelumbo nucifera leaf.
Lin MC; Kao SH; Chung PJ; Chan KC; Yang MY; Wang CJ
J Agric Food Chem; 2009 Jul; 57(13):5925-32. PubMed ID: 19499892
[TBL] [Abstract][Full Text] [Related]
25. Nonalcoholic fatty liver disease.
Angulo P
Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
[TBL] [Abstract][Full Text] [Related]
26. Hepatic triglyceride synthesis and nonalcoholic fatty liver disease.
Choi SS; Diehl AM
Curr Opin Lipidol; 2008 Jun; 19(3):295-300. PubMed ID: 18460922
[TBL] [Abstract][Full Text] [Related]
27. Long-term administration of rapamycin reduces adiposity, but impairs glucose tolerance in high-fat diet-fed KK/HlJ mice.
Chang GR; Wu YY; Chiu YS; Chen WY; Liao JW; Hsu HM; Chao TH; Hung SW; Mao FC
Basic Clin Pharmacol Toxicol; 2009 Sep; 105(3):188-98. PubMed ID: 19496779
[TBL] [Abstract][Full Text] [Related]
28. Insulin secretion after dietary supplementation with conjugated linoleic acids and n-3 polyunsaturated fatty acids in normal and insulin-resistant mice.
Winzell MS; Pacini G; Ahrén B
Am J Physiol Endocrinol Metab; 2006 Feb; 290(2):E347-54. PubMed ID: 16188912
[TBL] [Abstract][Full Text] [Related]
29. Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease.
Hong X; Tang H; Wu L; Li L
J Pharm Pharmacol; 2006 Oct; 58(10):1391-8. PubMed ID: 17034663
[TBL] [Abstract][Full Text] [Related]
30. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
[TBL] [Abstract][Full Text] [Related]
31. Swimming training beneficial effects in a mice model of nonalcoholic fatty liver disease.
Schultz A; Mendonca LS; Aguila MB; Mandarim-de-Lacerda CA
Exp Toxicol Pathol; 2012 May; 64(4):273-82. PubMed ID: 20869214
[TBL] [Abstract][Full Text] [Related]
32. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease.
Alwayn IP; Gura K; Nosé V; Zausche B; Javid P; Garza J; Verbesey J; Voss S; Ollero M; Andersson C; Bistrian B; Folkman J; Puder M
Pediatr Res; 2005 Mar; 57(3):445-52. PubMed ID: 15659701
[TBL] [Abstract][Full Text] [Related]
33. Betaine improved adipose tissue function in mice fed a high-fat diet: a mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver disease.
Wang Z; Yao T; Pini M; Zhou Z; Fantuzzi G; Song Z
Am J Physiol Gastrointest Liver Physiol; 2010 May; 298(5):G634-42. PubMed ID: 20203061
[TBL] [Abstract][Full Text] [Related]
34. Inflammation in nonalcoholic steatohepatitis.
Harmon RC; Tiniakos DG; Argo CK
Expert Rev Gastroenterol Hepatol; 2011 Apr; 5(2):189-200. PubMed ID: 21476914
[TBL] [Abstract][Full Text] [Related]
35. Regular exercise prevents high-sucrose diet-induced fatty liver via improvement of hepatic lipid metabolism.
Aoi W; Naito Y; Hang LP; Uchiyama K; Akagiri S; Mizushima K; Yoshikawa T
Biochem Biophys Res Commun; 2011 Sep; 413(2):330-5. PubMed ID: 21893033
[TBL] [Abstract][Full Text] [Related]
36. Update on nonalcoholic fatty liver disease: genes involved in nonalcoholic fatty liver disease and associated inflammation.
Tilg H; Moschen A
Curr Opin Clin Nutr Metab Care; 2010 Jul; 13(4):391-6. PubMed ID: 20473151
[TBL] [Abstract][Full Text] [Related]
37. Dietary modulation of clostridial cluster XIVa gut bacteria (Roseburia spp.) by chitin-glucan fiber improves host metabolic alterations induced by high-fat diet in mice.
Neyrinck AM; Possemiers S; Verstraete W; De Backer F; Cani PD; Delzenne NM
J Nutr Biochem; 2012 Jan; 23(1):51-9. PubMed ID: 21411304
[TBL] [Abstract][Full Text] [Related]
38. Hepatoprotective effect of oleuropein in mice: mechanisms uncovered by gene expression profiling.
Kim Y; Choi Y; Park T
Biotechnol J; 2010 Sep; 5(9):950-60. PubMed ID: 20845385
[TBL] [Abstract][Full Text] [Related]
39. Hepatic ratio of phosphatidylcholine to phosphatidylethanolamine predicts survival after partial hepatectomy in mice.
Ling J; Chaba T; Zhu LF; Jacobs RL; Vance DE
Hepatology; 2012 Apr; 55(4):1094-102. PubMed ID: 22095799
[TBL] [Abstract][Full Text] [Related]
40. Effects of lotus root (the edible rhizome of Nelumbo nucifera) on the deveolopment of non-alcoholic fatty liver disease in obese diabetic db/db mice.
Tsuruta Y; Nagao K; Shirouchi B; Nomura S; Tsuge K; Koganemaru K; Yanagita T
Biosci Biotechnol Biochem; 2012; 76(3):462-6. PubMed ID: 22451385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
